Actively Recruiting
A Study to Learn More About Prevenar 20 Once it is Out in the Korean Market
Led by Pfizer · Updated on 2026-03-12
660
Participants Needed
1
Research Sites
67 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The purpose of this study is to understand the safety of Prevenar 20 (Pneumococcal 20-valent conjugate vaccine) once it is out in the Korean market. Prevenar 20 will be given to participants aged 6 weeks or older in Republic of Korea. This study is seeking for participants who are: * Infant, children and adolescents aged 6 weeks to under 18 years or adult who are 18 years or older * Prescribed Prevenar 20 by their physician as per approved product label All participants in this study will receive Prevenar 20 vaccine. 1 dose (0.5 mL) of Prevenar 20 will be given into a muscle, preferably to the shoulder muscle. We will look at the experiences of people receiving the study medicine. This will help us see if the study medicine is safe. Participants will take part in this study for 28 days. During this time, study doctor collects the data of subjects to understand the safety of study medicine. There is no strict fixed visit schedule. If subjects are unable to visit the study clinic 28 days after Prevenar 20 vaccine was given then the safety information will be collected by telephone or e-mail.
CONDITIONS
Official Title
A Study to Learn More About Prevenar 20 Once it is Out in the Korean Market
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Infant, children and adolescents aged 6 weeks to under 18 years or adults 18 years or older
- Prescribed Prevenar 20 by their physician as per approved product label
- Signed informed consent by the subject or parent/legal guardian confirming understanding of the study
You will not qualify if you...
- Contraindication to Prevenar 20 according to the approved product label
- Does not agree that Pfizer and its partners can use their information
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Pfizer Korea
Seoul, South Korea
Actively Recruiting
Research Team
P
Pfizer CT.gov Call Center
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here